// App-Quantinova.ai

: MAJOR ADVERSE CARDIAC EVENTS AND VENOUS THROMBOEMBOLISM RISK WITH JAK INHIBITORS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Researchers

Presenter

  • Muhammad Haisum Maqsood

Principal Investigators

  • Molly Ottensoser

  • Jeffrey S. Berger

  • Sripal Bangalore

  • Michael Seth Garshick

Medical Centers

  • New York University School of Medicine, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Janus kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Prospective

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved